MedPath

Perioperative Aspirin Usage Survey

Terminated
Conditions
Surgery
Cardiovascular Disease
Interventions
Behavioral: Survey
Registration Number
NCT02561507
Lead Sponsor
University of New Mexico
Brief Summary

This is a survey of members of the American College of Surgeons (ACS), to describe and explore current patterns of their decisions about withholding or continuation for patients taking aspirin (ASA) in the perioperative period. Secondarily, the survey will also explore surgeons' knowledge about the risks and benefits attending this decision, and about national organizations' recommendations.

Detailed Description

An announcement of the survey and invitation to participate will be posted in the "ACS Surgery News" newsletter published by the American College of Surgeons. Surgeons of all specialties will be invited to participate. No identifiers will be maintained with survey responses. In addition to the substantive questions below, typical demographic data will be obtained including participants' duration of practice, specialty, gender, state, etc.

The survey will include questions intended to characterize current practice surrounding the decision to continue or withhold aspirin in the perioperative period. Other questions will focus on surgeons' knowledge of national medical/surgical organizations that have published guidelines on the perioperative use of aspirin. Finally, other survey questions will characterize surgeons' knowledge of the platelet rebound effect.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Members of the American College of Surgeons
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
American College of Surgeons membersSurveySurvey participants
Primary Outcome Measures
NameTimeMethod
Typical proportion of participants' patients given a recommendation to stop taking aspirinAt time of survey; generally less than 20 minutes
Proportion of participants correctly identifying national organizations with perioperative aspirin recommendationsAt time of survey; generally less than 20 minutes
Proportion of participants correctly answering questions about platelet rebound effectAt time of survey; generally less than 20 minutes
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of New Mexico Hospital

🇺🇸

Albuquerque, New Mexico, United States

© Copyright 2025. All Rights Reserved by MedPath